IFIRMASTA

This brand name is authorized in Albania, Austria, Croatia, Estonia, France, Germany, Ireland, Italy, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug IFIRMASTA contains one active pharmaceutical ingredient (API):

1
UNII J0E2756Z7N - IRBESARTAN
 

Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II. The selective antagonism of the angiotensin-II (AT1) receptors results in increases in plasma renin levels and angiotensin-II levels, and a decrease in plasma aldosterone concentration.

 
Read more about Irbesartan

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 IFIRMASTA Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09CA04 Irbesartan C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AL Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor 366/73, 367/73
DE Bundesinstitut für Arzneimittel und Medizinprodukte 09726342, 09726359, 09726365, 09726371, 09726388, 09726394, 09726402, 09726419, 09726425
EE Ravimiamet 1391868, 1391879, 1391880, 1391891, 1391903, 1391914, 1391925, 1391936, 1391947, 1391958, 1391969, 1391970, 1391981, 1391992, 1392005, 1598531, 1598542, 1598553, 1598564, 1598575, 1598586
ES Centro de información online de medicamentos de la AEMPS 08480002, 08480008, 08480014
FR Base de données publique des médicaments 60488216, 60582498, 66542998
GB Medicines & Healthcare Products Regulatory Agency 227204, 227207, 227209
IE Health Products Regulatory Authority 54317, 54318, 54319
IT Agenzia del Farmaco 041666088, 041666140
LT Valstybinė vaistų kontrolės tarnyba 1035185, 1035186, 1035187, 1035188, 1035189, 1035190, 1035191, 1035192, 1035193, 1035194, 1035195, 1035196, 1035198, 1035199, 1035200, 1035201, 1035202, 1035203, 1069774, 1069775, 1069776, 1069777, 1069778, 1069779
PL Rejestru Produktów Leczniczych 100310677, 100310690, 100310720
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W55941001, W55941002, W55941003, W55941004, W55941005, W55941006, W55942001, W55942002, W55942003, W55942004, W55942005, W55942006, W55943001, W55943002, W55943003, W55943004, W55943005, W55943006

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.